Back to search
Congenital Profound Hearing Loss
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Congenital Profound Hearing Loss trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Congenital Profound Hearing Loss trials you may qualify forThe purpose of this study is to follow the natural history of non-syndromic hearing loss caused by mutations in two genes (GJB2 or OTOF) in children up to 16 ye…
The language environment that influences the child's language development has been studied using different subjective tools, mainly audio and/or video recording…
This study intends to assess safety, tolerability, and efficacy of SENS-501 in children between the ages of 6-31 months with pre-lingual hearing loss due to a m…
Evaluation of a cohort of deaf children looking for autosomal recessive deafness-9 (DFNB9). Clinical and audiologic evaluation of patients with known auditive…
Current treatment options for bilateral profoundly deaf children, diagnosed with inner ear anatomical abnormalities, are limited and, in the case of absent coch…
The Nucleus 24 Auditory Brainstem Implant (ABI) is the only FDA approved device for restoration of meaningful hearing in Neurofibromatosis Type 2 (NF2) patients…